Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue
Sales	$ 1,177	$ 48,021
Grant revenue	77,482	161,974
Total revenue	78,659	209,995
Cost of sales	690	57,690
Gross profit	77,969	152,305
Operating expenses
Research and development	1,568,266	530,076
General and administrative	2,506,851	2,170,857
Total operating expenses	4,075,117	2,700,933
Operating loss	(3,997,148)	(2,548,628)
Other (income) and expenses
Interest and dividend income	(44,879)	(36,463)
Other income		(190,193)
Unrealized (gain)/loss on marketable equity securities	(54,508)	43,078
Realized loss on marketable equity securities	106,324
Change in fair value of convertible notes		195,962
Loss on extinguishment of convertible notes		934,257
Interest expense	90,748	208,289
Net loss	(4,094,833)	(3,703,558)
Other comprehensive income
Unrealized gain on marketable debt securities	22,451
Total comprehensive loss	$ (4,072,382)	$ (3,703,558)
Net loss per share - basic and diluted (in Dollars per share)	$ (0.34)	$ (0.51)
Weighted average common shares - basic and diluted (in Shares)	11,886,379	7,216,001